Lepodisiran

(Synonyms: LY3819469)
Customer Review

Based on 1 Customer Validation

Lepodisiran (LY3819469) is a GalNAc-conjugated, injectable small interfering RNA lipid-lowering agent characterized by rapid hepatic uptake and long-lasting effects. Lepodisiran targets the hepatic LPA gene and degrades apolipoprotein (a) mRNA to silence its expression, thereby effectively reducing the production of apolipoprotein (a) and serum lipoprotein (a) in a dose-dependent manner. Lepodisiran can be used in research related to atherosclerotic cardiovascular disease.

For research use only. We do not sell to patients.

  • Purity: 91.95%
  • CAS No.: 2808361-18-2
  • Molecular Weight:20720.00
  • Storage:

    -20°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Apolipoprotein Isoforms

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00